University of California, Irvine
3 clinical trials · 3 recruiting · OTHER
Trials by University of California, Irvine
RECRUITINGPhase 2NCT06771544
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
This is a phase 2, single-arm, open label clinical trial determining efficacy of Cyclophosphamide and Pembrolizumab in subjects with melanoma.
Sponsor: University of California, IrvineEnrolling: 141 location
MelanomaMelanoma Stage IIIMelanoma (Skin)+1
RECRUITINGPhase 4NCT05582837
Treatment of Meniere's Disease With Migraine Medications
Meniere's disease (MD) is a chronic disease with a variety of fluctuating signs and symptoms, which include vertigo, hearing loss, tinnitus (ringing noise in the ear), aural...
Sponsor: University of California, IrvineEnrolling: 1001 location
Ménière
RECRUITINGNCT06853158
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
This is a multi-site, multi-visit feasibility RCT of music therapy (MT) among adolescent and adult patients (aged 14 and older) with sickle cell disease (SCD). Subjects will be...
Sponsor: University of California, IrvineEnrolling: 902 locations
Sickle Cell Disease